[1]
D. Azboy and Z. Temiztürk, “Clinical Outcomes after Biologic Graft Use for the Creation of Blalock-Taussig Shunt in Critically Ill Patients with Thrombophilia”, HSF, vol. 23, no. 6, pp. E718-E724, Oct. 2020.